BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25568177)

  • 41. Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection.
    Heim CE; Vidlak D; Scherr TD; Kozel JA; Holzapfel M; Muirhead DE; Kielian T
    J Immunol; 2014 Apr; 192(8):3778-92. PubMed ID: 24646737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
    Schmid M; Zimara N; Wege AK; Ritter U
    Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes.
    Raychaudhuri B; Rayman P; Huang P; Grabowski M; Hambardzumyan D; Finke JH; Vogelbaum MA
    J Neurooncol; 2015 Apr; 122(2):293-301. PubMed ID: 25579983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resiquimod, a TLR7/8 agonist, promotes differentiation of myeloid-derived suppressor cells into macrophages and dendritic cells.
    Lee M; Park CS; Lee YR; Im SA; Song S; Lee CK
    Arch Pharm Res; 2014; 37(9):1234-40. PubMed ID: 24748512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
    Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
    Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
    Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency.
    Green KA; Cook WJ; Green WR
    J Virol; 2013 Feb; 87(4):2058-71. PubMed ID: 23221564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1.
    Jackson AR; Hegde VL; Nagarkatti PS; Nagarkatti M
    J Leukoc Biol; 2014 Apr; 95(4):609-19. PubMed ID: 24319288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
    Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
    Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Cisplatin on the Frequency and Immuno-inhibitory Function of Myeloid-derived Suppressor Cells in A375 Melanoma Model.
    Huang X; Guan D; Shu YQ; Liu LK; Ni F
    Asian Pac J Cancer Prev; 2015; 16(10):4329-33. PubMed ID: 26028094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes.
    Watanabe S; Deguchi K; Zheng R; Tamai H; Wang LX; Cohen PA; Shu S
    J Immunol; 2008 Sep; 181(5):3291-300. PubMed ID: 18714001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis.
    Iacobaeus E; Douagi I; Jitschin R; Marcusson-Ståhl M; Andrén AT; Gavin C; Lefsihane K; Davies LC; Mougiakakos D; Kadri N; Le Blanc K
    Immunol Cell Biol; 2018 Sep; 96(8):820-830. PubMed ID: 29569304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. mTOR limits the recruitment of CD11b+Gr1+Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury.
    Zhang Y; Bi Y; Yang H; Chen X; Liu H; Lu Y; Zhang Z; Liao J; Yang S; Chu Y; Yang R; Liu G
    J Leukoc Biol; 2014 Jun; 95(6):961-70. PubMed ID: 24569105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients.
    Jordan KR; Amaria RN; Ramirez O; Callihan EB; Gao D; Borakove M; Manthey E; Borges VF; McCarter MD
    Cancer Immunol Immunother; 2013 Nov; 62(11):1711-22. PubMed ID: 24072401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating myeloid-derived suppressor cells in patients with pancreatic cancer.
    Xu XD; Hu J; Wang M; Peng F; Tian R; Guo XJ; Xie Y; Qin RY
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):99-105. PubMed ID: 26818550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.
    OuYang LY; Wu XJ; Ye SB; Zhang RX; Li ZL; Liao W; Pan ZZ; Zheng LM; Zhang XS; Wang Z; Li Q; Ma G; Li J
    J Transl Med; 2015 Feb; 13():47. PubMed ID: 25638150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD1d is a novel cell-surface marker for human monocytic myeloid-derived suppressor cells with T cell suppression activity in peripheral blood after allogeneic hematopoietic stem cell transplantation.
    An B; Lim JY; Jeong S; Shin DM; Choi EY; Min CK; Hong SH
    Biochem Biophys Res Commun; 2018 Jan; 495(1):519-525. PubMed ID: 29108995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
    Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
    Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunosuppressive CD11b+Ly6Chi monocytes in pristane-induced lupus mouse model.
    Ma H; Wan S; Xia CQ
    J Leukoc Biol; 2016 Jun; 99(6):1121-9. PubMed ID: 26657791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.